Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.06% Nasdaq Down0.01%

Biostar Pharmaceuticals, Inc. (BSPM)

-NasdaqGM

0.79 0.00(0.00%) 3:59PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 12,092   15,290   9,969   8,159  
Cost of Revenue5,403  6,088  4,730  3,586  
Gross Profit 6,689   9,202   5,239   4,573  
Operating Expenses
Research Development796  2,105  790  790  
Selling General and Administrative5,162  10,362  10,246  16,021  
Non Recurring -  3,675   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 731   (6,940) (5,796) (12,238)
Income from Continuing Operations
Total Other Income/Expenses Net453  49  56  96  
Earnings Before Interest And Taxes1,184  (6,891)(5,740)(12,142)
Interest Expense96  51  1  17  
Income Before Tax1,089  (6,943)(5,741)(12,159)
Income Tax Expense528  (200)199  (2,676)
Minority Interest -   -   -   -  
Net Income From Continuing Ops561  (6,743)(5,940)(9,483)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 561   (6,743) (5,940) (9,483)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 561   (6,743) (5,940) (9,483)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.